StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2023 - 12 - 11
8
2023 - 11 - 27
8
2023 - 10 - 25
11
2023 - 10 - 12
9
2023 - 07 - 17
10
2023 - 07 - 11
8
2023 - 06 - 28
9
2023 - 05 - 09
11
2023 - 03 - 28
10
2023 - 03 - 23
8
2023 - 02 - 28
8
2023 - 02 - 22
9
2023 - 01 - 05
7
2022 - 12 - 15
7
2022 - 10 - 24
7
2022 - 09 - 14
7
2022 - 06 - 21
8
2022 - 05 - 24
12
2022 - 05 - 18
8
2022 - 05 - 11
7
2022 - 05 - 09
9
2022 - 03 - 16
10
2022 - 03 - 15
7
2022 - 03 - 03
7
2022 - 02 - 28
8
2022 - 02 - 24
10
2022 - 02 - 14
7
2022 - 01 - 05
10
2021 - 12 - 07
8
2021 - 11 - 30
8
2021 - 11 - 18
7
2021 - 11 - 16
7
2021 - 11 - 11
10
2021 - 11 - 03
7
2021 - 10 - 25
7
2021 - 10 - 19
9
2021 - 10 - 12
8
2021 - 09 - 22
7
2021 - 08 - 24
7
2021 - 08 - 23
7
2021 - 08 - 17
7
2021 - 07 - 29
9
2021 - 07 - 27
8
2021 - 07 - 22
8
2021 - 07 - 07
7
2021 - 06 - 24
9
2021 - 06 - 22
8
2021 - 06 - 17
7
2021 - 06 - 16
10
2021 - 06 - 10
7
2021 - 06 - 08
7
2021 - 05 - 24
10
2021 - 05 - 17
8
2021 - 05 - 03
8
2021 - 04 - 13
9
2021 - 04 - 08
7
2021 - 02 - 26
8
2021 - 02 - 22
8
2021 - 02 - 08
9
2021 - 01 - 11
7
Sector
Health technology
9
Tags
5g
4
Acquisition
5
Alzheimer
4
Alzheimer's
4
Alzheimer's disease
4
Alzheimer’s
4
Application
3
Approval
5
Biopharma
4
Bioscience
4
Biotech-bay
4
Cancer
5
Ceo
3
Clinical-trials-phase-ii
3
Collaboration
6
Communication
5
Communications
5
Conference
35
Covid
7
Designation
4
Diabetes
5
Disease
9
Distribution
11
Drug
5
Earnings
7
Energy
13
Europe
3
Ev
7
Events
3
Expansion
4
Fda
10
Fda approval
3
Fda-approvals
3
Financial report
3
Financial results
62
Growth
23
India
3
Liver
4
Market
6
Media
6
Medical-device
4
Merge
5
Mobile
5
Money
8
N/a
419
Offering
12
Patent
4
People
5
Positive
5
Publication
7
Report
13
Research
9
Results
129
Sales
5
Technology
5
Test
4
Therapy
6
Treatment
7
Trial
6
Vaccine
7
Entities
Abbvie inc.
1
Ac immune sa
1
Anavex life sciences corp.
1
Arrowhead pharmaceuticals, inc.
1
Biogen inc.
1
Cassava sciences, inc.
2
Eli lilly and company
1
Galapagos nv
1
Gilead sciences, inc.
1
Johnson & johnson
1
Novo nordisk a/s
1
Sanofi
1
Takeda pharmaceutical company limited
1
Symbols
ABBV
1
ACIU
1
ARWR
1
AVXL
1
BIIB
1
GILD
1
GLPG
1
JNJ
1
LLY
1
NVO
1
SAVA
2
SNY
1
TAK
1
Exchanges
Nasdaq
9
Nyse
3
Crawled Date
2021 - 07 - 29
9
Crawled Time
11:00
2
12:00
1
14:00
2
15:15
1
18:00
1
20:00
1
21:00
1
Source
www.anavex.com
1
www.biospace.com
2
www.globenewswire.com
3
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 07 - 29
tags :
Disease
save search
Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021
Published:
2021-07-29
(Crawled : 21:00)
- biospace.com/
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-41.6%
|
O:
0.24%
H:
0.58%
C:
-1.74%
disease
alzheimer
alzheimer’s
alzheimer's disease
alzheimer's
designation
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Published:
2021-07-29
(Crawled : 20:00)
- biospace.com/
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-23.23%
|
O:
0.0%
H:
0.06%
C:
-1.17%
ARWR
|
$22.62
0.4%
0.4%
1.3M
|
Health Technology
|
-65.38%
|
O:
1.95%
H:
1.82%
C:
-1.98%
disease
liver disease
treatment
fda
therapy
breakthrough therapy
liver
designation
Crohn's Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30
Published:
2021-07-29
(Crawled : 18:00)
- prnewswire.com
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
204.56%
|
O:
0.4%
H:
0.3%
C:
-0.88%
GLPG
|
$28.9
-1.1%
-1.11%
140K
|
Health Technology
|
-52.15%
|
O:
1.31%
H:
0.45%
C:
-2.15%
disease
growth
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published:
2021-07-29
(Crawled : 15:15)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
36.11%
|
O:
0.49%
H:
0.26%
C:
-0.62%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-15.81%
|
O:
0.33%
H:
0.35%
C:
-0.32%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
39.32%
|
O:
0.4%
H:
0.08%
C:
-0.13%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.58%
|
O:
-0.69%
H:
0.08%
C:
-0.33%
disease
therapy
molecular
growth
research
merge
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease
Published:
2021-07-29
(Crawled : 14:00)
- globenewswire.com
SAVA
|
$21.18
-0.42%
-0.42%
970K
|
Health Technology
|
-84.28%
|
O:
7.17%
H:
0.8%
C:
-28.72%
disease
alzheimer
positive
alzheimer’s
alzheimer's disease
alzheimer's
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease
Published:
2021-07-29
(Crawled : 14:00)
- globenewswire.com
SAVA
|
$21.18
-0.42%
-0.42%
970K
|
Health Technology
|
-84.28%
|
O:
7.17%
H:
0.8%
C:
-28.72%
disease
alzheimer
positive
alzheimer’s
alzheimer's disease
alzheimer's
biomarkers
AC Immune Presents Full Phase 1b Results on Anti-Abeta Vaccine and Discusses its First-in-Class Diagnostic for Parkinson’s Disease at AAIC 2021
Published:
2021-07-29
(Crawled : 12:00)
- globenewswire.com
ACIU
|
$2.38
-1.65%
0.41%
370K
|
Health Technology
|
-67.71%
|
O:
2.04%
H:
1.06%
C:
-5.45%
disease
phase 1
results
parkinson
vaccine
phase 1b
diagnostic
phase 2b
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
Published:
2021-07-29
(Crawled : 11:00)
- prnewswire.com
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-4.51%
|
O:
0.27%
H:
0.21%
C:
-0.6%
disease
fda
cancer
breast cancer
designation
rare
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Significantly Prevented Aβ (Abeta)-induced Cognitive Deficits with Confirmed Significant Biomarker-response in Animal Model of Alzheimer’s Disease
Published:
2021-07-29
(Crawled : 11:00)
- anavex.com
AVXL
|
$3.8
-6.63%
-7.11%
1.7M
|
Health Technology
|
-82.21%
|
O:
2.67%
H:
0.27%
C:
-16.6%
disease
alzheimer
life science
anavex®2-73
anavex
alzheimer’s
alzheimer's disease
alzheimer's
biomarkers
Gainers vs Losers
63%
37%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.